MetLife Investment Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

MetLife Investment Management’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-46,389	Closed	-$309K	–	2881
2023 Q3	$309K	Hold	46,389	–	–	﹤0.01%	1930
2023 Q2	$420K	Hold	46,389	–	–	﹤0.01%	1814
2023 Q1	$337K	Hold	46,389	–	–	﹤0.01%	1889
2022 Q4	$338K	Buy	46,389 +5,454	+13%	+$40.5K	﹤0.01%	1888
2022 Q3	$316K	Hold	40,935	–	–	﹤0.01%	1977
2022 Q2	$279K	Buy	+40,935	New	+$313K	﹤0.01%	2067

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

MetLife Investment Management's PNT Position: Q4 2023 in Review

MetLife Investment Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 46,389 shares — an estimated $309K sold.

MetLife Investment Management first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $420K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

MetLife Investment Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
MetLife Investment Management sold 46,389 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $309K.
MetLife Investment Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
MetLife Investment Management's POINT Biopharma Global Inc. Common Stock position peaked at $420K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on MetLife Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.